Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Advances in Kidney Cancer Diagnosis: Current Approaches and Future Perspectives

Hamid Saeedi*

Kidney cancer, also known as renal cell carcinoma (RCC), is a prevalent urological malignancy with substantial morbidity and mortality. Timely and accurate diagnosis is essential for effective treatment and improved patient outcomes. Recent advancements in diagnostic approaches, including imaging modalities, biomarker discovery, liquid biopsy, molecular profiling, and artificial intelligence, have revolutionized kidney cancer diagnosis. This research article provides a comprehensive overview of the current state of kidney cancer diagnosis and explores the potential future perspectives. It discusses traditional and advanced diagnostic methods, the role of biomarkers, and the promise of liquid biopsy in non-invasive diagnosis. Furthermore, it highlights the contribution of genomic analysis and artificial intelligence in improving diagnostic accuracy. Integrative diagnostic approaches are also examined, which amalgamate multiple diagnostic modalities for better patient management. With a deeper understanding of kidney cancer’s molecular basis, innovative diagnostic technologies hold the potential to enhance early detection rates and pave the way for personalized treatment strategies.